Liquid-liquid extraction procedure for trace determination of cyclophosphamide in human urine by high-performance liquid chromatography tandem mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 12, Issue 16, 1998, Pages 1063-1068

  Sottani, Cristina ^a   Turci, Roberta ^a   Perbellini, Luigi ^b   Minoia, Claudio ^a  

^a IRCCS   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; DRUG PRODUCTS; EFFICIENCY; MASS SPECTROMETRY; SOLVENT EXTRACTION;

DRUG PREPARATION; EXTRACTION EFFICIENCIES; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; HUMAN URINE; IONSPRAY; LIQUID-LIQUID EXTRACTION PROCEDURE; TANDEM MASS SPECTROMETRY; TANDEM-MASS SPECTROMETRY; TRACE DETERMINATION;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0031851155     PISSN: 09514198     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0231(19980831)12:16<1063::aid-rcm287>3.3.co;2-b     Document Type: Article

References (23)

1. J. F. Hooland and E. Frei III, Cancer Medicine, Lea and Febiger, Philadephia (1973).
2. N. E. Sladek, Pharmacol Ther. 37, 301 (1988).
3. J. T. Slattery, T. F. Kalhorn, G. B. McDonal, K. Lambert, C. D. Buckner, W. I. Besiger, C. Anasetti and F. R. Appelbaum, J. Clinical Oncol. 14, 1848 (1996).
4. R. F. Struck, M. C. Kirk, M. H. Witt and W. L. Russell Jr, Biomed. Mass Spectrom. 2, 46 (1975).
5. J. E. Low, R. F. Borch and N. E. Sladek, Cancer Res. 42, 830 (1982).
6. M. Hirst, D. G. Millis, Tse S. Levin and D. F. White, Lancet 1, 186 (1984).
7. M. Sorsa and D. Anderson, Mutat. Res. 335, 253 (1996).
8. K. Falck, P. Grohn, M. Sorsa, H. Vainio, E. Heinoen and L. R. Holsti, Lancet 1, 1250 (1979).
9. S. Venitt, C. Crofton-Sleight, J. Hunt, V. Speechley and K. Briggs, Lancet 1, 74 (1984).
10. O. Jagun, M. Rayan and H. A. Waldron, Lancet ii, 446 (1982).
11. S. Hansel, M. Castegnaro, M. H. Sportouch, M. De Meo, J. C. Milhavet, M. Laget and G. Dumenil, Int. Arch. Occup. Environ. Health 69, 109 (1997).
12. A. C. Metha and R. T. Calvert, J. Chromatogr. 421, 377 (1987).
13. E. A. De Bruin, U. R. Tjaden, A. T. Van Oosterom, P. Leeflang and P. A. Leclercq, J. Chromatogr. 279, 603 (1983).
14. A. El-Yazigi and C. R. Martin, J. Chromatogr. 374, 177 (1986).
15. P. J. M. Sessink, M. M. Scholtes, R. B. Anzion and R. P. Bos, J. Chromatogr. 616, 333 (1993).
16. G. Momerency, K. Van Cauwenberge, P. H. Th. J. Slee and A. T. Van Oosterom, Biol. Mass Spectrom. 23, 149 (1994).
17. P. J. M. Sessink, W. H. J. Vaes, P. H. H. van der Broek, J. Noordhoek and R. P. Bos, J. Chromatogr. 673, 205 (1995).
18. R. W. Hardy, C. Erlichman and S. J. Soldin, Ther. Drug Monit. 6, 313 (1984).
19. L. C. Burton and C. A. James, J. Chromatogr. 431, 450 (1988).
20. H. R. Shulten, J. Chromatogr. 251, 105 (1984).
21. H. R. Shulten, Biomed Mass Spectrom. 8, 553 (1981).
22. A. S. Ensslin, Y. Stoll, A. Perthan, A. Pfaller, H. Rommelt and G. Fruhmann, Occ. Environ. Med. 51, 229 (1994).
23. C. T. A. Evelo, R. P. Bos, J. G. P. Peter and P. Th. Henderson, Am. J. Hosp. Pharm. 43, 1942 (1986).